Cytecare on the Future of Oncology: AI, Precision Medicine, & Better Patient Outcomes
Bengaluru (Karnataka) [India], March 10: The word “cancer” carries an undeniable weight. A diagnosis can be life-altering, not just for the patient but for their entire family. In India, where cancer remains one of the leading causes of death – with 1.16 million new cases and 784,000 cancer-related deaths reported annually – the burden is immense. But while cancer has long been associated with fear and uncertainty, advancements in medical technology are changing the landscape. Artificial intelligence (AI), precision medicine, and cutting-edge treatments are transforming oncology, making early detection more accurate, treatments more effective, and patient outcomes more hopeful.
“AI is playing a pivotal role in revolutionizing cancer care, particularly in early detection,” says Suresh Ramu, Co-founder and CEO of Cytecare Hospitals. “By analyzing medical images with incredible precision, AI helps detect anomalies that might be missed by the human eye. For example, AI-assisted mammography is particularly useful for women with dense breast tissue, a group that has historically faced challenges in early breast cancer detection.” Studies have already shown that AI-powered diagnostic tools can match or even surpass human experts in accuracy. The result? Faster diagnoses, fewer false positives and negatives, and a greater ability to identify cancer in its earliest, most treatable stages.........
© News9Live
